// App-Quantinova.ai

: The Impact of Momelotinib on Patient Reported Quality of Life for Symptomatic and Anemic Patients with Myelofibrosis: Results from the Phase 3 Momentum Study

Researchers

Presenter

  • Ruben Mesa

Principal Investigators

  • Jeanne M. Palmer

  • Vikas Gupta

  • Donal P. McLornan

  • Mary Frances McMullin

  • Jean-Jacques Kiladjian

  • Lynda Foltz

  • Uwe Platzbecker

  • Maria Laura Fox

  • Adam J Mead

  • David M Ross

  • Stephen T Oh

  • Andrew Charles Perkins

  • Michael F. Leahy

  • Jun Kawashima

  • Sunhee Ro

  • Rafe Donahue

  • Samineh Deheshi

  • Srdan Verstovsek

Medical Centers

  • Mayo Clinic, Phoenix, AZ

  • University Hospital Leipzig, Leipzig, Germany

  • PathWest Laboratory Medicine WA, Perth, Australia

  • Haematology Department, Guy's and St Thomas’ NHS Trust, London, United Kingdom

  • Guy's and St Thomas’ NHS Foundation Trust, London, United Kingdom

  • Royal Adelaide Hospital and SA Pathology, Adelaide, Australia

  • Centre for Medical Education, Queen's University, Belfast, United Kingdom

  • MD Anderson Cancer Center, University of Texas, Houston, TX

  • University Hospital Vall d'Hebron, Barcelona, Spain

  • Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

  • UT Health San Antonio Cancer Center, San Antonio, TX

  • University of British Columbia, Vancouver, Canada

  • Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO

  • Division of Medical Oncology and Hematology, University Health Network, Toronto, Canada

  • Australian Centre For Blood Diseases, Monash University, Melbourne, Australia

  • Clinical Investigations Center, Saint-Louis hospital, Université de Paris, Paris, France

Locations

  • United States

  • United Kingdom

  • Spain

  • Germany

  • Australia

  • Canada

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myelofibrosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Momelotinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved